Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-16

FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved Lupin's dextroamphetamine sulfate as an original ANDA, enabling a generic version of the stimulant for ADHD and narcolepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextroamphetamine sulfate (dextroamphetamine sulfate)

Snippet

ORIG AP for DEXTROAMPHETAMINE SULFATE (DEXTROAMPHETAMINE SULFATE)